Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 3/20 | 0.63 |
| ▸ | CHRNA1 | P02708 | 3/20 | 0.62 |
| ▸ | CHRNG | P07510 | 3/20 | 0.62 |
| ▸ | CHRNB1 | P11230 | 3/20 | 0.62 |
| ▸ | CHRND | Q07001 | 3/20 | 0.62 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.62 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.62 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.59 |
| ▸ | ACE | P12821 | 6/20 | 0.59 |
| ▸ | CTSL | P07711 | 1/20 | 0.57 |
| ▸ | CTSB | P07858 | 1/20 | 0.57 |
| ▸ | CTSS | P25774 | 1/20 | 0.57 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.56 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.56 |
| ▸ | GPR34 | Q9UPC5 | 1/20 | 0.55 |
| ▸ | CPA1 | P15085 | 1/20 | 0.54 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4162326 | 1.00 | MME (0.63) | MMECHRNA1CHRNGCHRNB1CHRND | |
| SCHEMBL4160727 | 1.00 | MME (0.63) | MMECHRNA1CHRNGCHRNB1CHRND | |
| SCHEMBL4160723 | 1.00 | MME (0.63) | MMECHRNA1CHRNGCHRNB1CHRND | |
| SCHEMBL27840664 | 1.00 | MME (0.63) | MMECHRNA1CHRNGCHRNB1CHRND | |
| SCHEMBL4161387 | 0.95 | ACE (0.62) | MMECHRNA1CHRNGCHRNB1CHRND | |
| SCHEMBL4161392 | 0.95 | ACE (0.62) | MMECHRNA1CHRNGCHRNB1CHRND | |
| SCHEMBL28522339 | 0.93 | CHRNA1 (0.60) | MMECHRNA1CHRNGCHRNB1CHRND | |
| SCHEMBL10504767 | 0.92 | ITGB3 (0.65) | MMEITGB3ITGA2BACECTSL | |
| SCHEMBL4144665 | 0.92 | ITGB3 (0.65) | MMEITGB3ITGA2BACECTSL | |
| SCHEMBL4144668 | 0.92 | ITGB3 (0.65) | MMEITGB3ITGA2BACECTSL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112384495-B | Novel modulators of metabotropic and ion-channel transmembrane receptors and uses thereof | IBD治疗学有限责任公司 | 2023-07-18 | — | — | CN | claimed |
| EP-1876169-B1 | PHENYL-CONTAINING N-ACYL AMINE AND AMINOACID DERIVATIVES, METHODS FOR THE PRODUCTION THEREOF, A PHARMACEUTICAL COMPOSITION AND THE USE THEREOF | OBSCHESTVO S OGRANICHENNOI OTVETSTENNOSTIYU PHARMENTPR (RU) | 2015-12-30 | — | — | EP | claimed |
| CN-101180267-B | Phenyl-containing n-acyl amine and aminoacid derivatives, methods for the production thereof, a pharmaceutical composition and the use thereof | OBSCHESTVO S OGRANICHENNOI OTV | 2015-06-17 | — | — | CN | claimed |
| US-8309766-B2 | Phenyl-containing n-acyl amine and aminoacid derivatives, methods for the production thereof, a pharmaceutical composition and the use thereof | Obschestvo S. Organichennoi Otvetstvennostiyu Pharmenterprises (RU) | 2012-11-13 | — | — | US | claimed |
| US-20090111874-A1 | Phenyl-containing n-acyl amine and aminoacid derivatives, methods for the production thereof, a pharmaceutical composition and the use thereof | OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU PHARMENTERPRISES (RU) | 2009-04-30 | — | — | US | claimed |
| EP-1876169-A1 | PHENYL-CONTAINING N-ACYL AMINE AND AMINOACID DERIVATIVES, METHODS FOR THE PRODUCTION THEREOF, A PHARMACEUTICAL COMPOSITION AND THE USE THEREOF | Obschestvo S Ogranichennoi Otvetstennostiyu "Pharmenterprises" (RU) | 2008-01-09 | — | — | EP | claimed |
| CN-110167547-B | Multi-target drugs for treating diseases in mammals | 欧亚制药有限责任公司 | 2024-04-05 | — | — | CN | disclosed |
| CN-112384495-B | Novel modulators of metabotropic and ion-channel transmembrane receptors and uses thereof | IBD治疗学有限责任公司 | 2023-07-18 | — | — | CN | disclosed |
| US-11584709-B2 | Multitarget drug for treating diseases in mammals | “PHARMENTERPRISES EURASIA” LIMITED LIABILITY COMPANY (RU) | 2023-02-21 | — | — | US | disclosed |
| US-11584709-B2 | Multitarget drug for treating diseases in mammals | “PHARMENTERPRISES EURASIA” LIMITED LIABILITY COMPANY (RU) | 2023-02-21 | — | — | US | disclosed |
| US-20210284600-A1 | NOVEL MULTITARGET DRUG FOR TREATING DISEASES IN MAMMALS | "PHARMENTERPRISES EURASIA" LIMETED LIABILITY COMPANY (RU) | 2021-09-16 | — | — | US | disclosed |
| US-20210284600-A1 | NOVEL MULTITARGET DRUG FOR TREATING DISEASES IN MAMMALS | "PHARMENTERPRISES EURASIA" LIMETED LIABILITY COMPANY (RU) | 2021-09-16 | — | — | US | disclosed |
| CN-112384495-A | Novel modulators of metabolic and ion channel transmembrane receptors and uses thereof | IBD治疗学有限责任公司 | 2021-02-19 | — | — | CN | disclosed |
| US-20130109880-A1 | PHENYL-N-ACYL DERIVATIVES OF AMINES AND AMINO ACIDS, A PROCESS FOR THE PREPARATION THEREOF, A PHARMACEUTICAL COMPOSITION AND USE THEREOF | OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU PHARMENTERPRISES (RU) | 2013-05-02 | — | — | US | disclosed |
| US-8309766-B2 | Phenyl-containing n-acyl amine and aminoacid derivatives, methods for the production thereof, a pharmaceutical composition and the use thereof | Obschestvo S. Organichennoi Otvetstvennostiyu Pharmenterprises (RU) | 2012-11-13 | — | — | US | disclosed |
| US-8309766-B2 | Phenyl-containing n-acyl amine and aminoacid derivatives, methods for the production thereof, a pharmaceutical composition and the use thereof | Obschestvo S. Organichennoi Otvetstvennostiyu Pharmenterprises (RU) | 2012-11-13 | — | — | US | disclosed |
| US-8309766-B2 | Phenyl-containing n-acyl amine and aminoacid derivatives, methods for the production thereof, a pharmaceutical composition and the use thereof | Obschestvo S. Organichennoi Otvetstvennostiyu Pharmenterprises (RU) | 2012-11-13 | — | — | US | disclosed |
| US-20090111874-A1 | Phenyl-containing n-acyl amine and aminoacid derivatives, methods for the production thereof, a pharmaceutical composition and the use thereof | OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU PHARMENTERPRISES (RU) | 2009-04-30 | — | — | US | disclosed |
| US-20090111874-A1 | Phenyl-containing n-acyl amine and aminoacid derivatives, methods for the production thereof, a pharmaceutical composition and the use thereof | OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU PHARMENTERPRISES (RU) | 2009-04-30 | — | — | US | disclosed |
| US-20090111874-A1 | Phenyl-containing n-acyl amine and aminoacid derivatives, methods for the production thereof, a pharmaceutical composition and the use thereof | OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU PHARMENTERPRISES (RU) | 2009-04-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210284600-A1 | NOVEL MULTITARGET DRUG FOR TREATING DISEASES IN MAMMALS | CTSB, CCKBR, BDKRB1 | MME 491/4885CHRNA1 1113/4885CHRNG 1099/4885 |
| US-20130109880-A1 | PHENYL-N-ACYL DERIVATIVES OF AMINES AND AMINO ACIDS, A PROCESS FOR THE PREPARATION THEREOF, A PHARMACEUTICAL COMPOSITION AND USE THEREOF | MAOA, PAH, MAOB | MME 613/4885CHRNA1 384/4885CHRNG 501/4885 |
| US-20090111874-A1 | Phenyl-containing n-acyl amine and aminoacid derivatives, methods for the production thereof, a pharmaceutical composition and the use thereof | PAH, MAOA, APEH | MME 634/4885CHRNA1 530/4885CHRNG 761/4885 |
| US-11584709-B2 | Multitarget drug for treating diseases in mammals | CTSB, CCKBR, BDKRB1 | MME 573/4885CHRNA1 1244/4885CHRNG 1234/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.